CONFERENCE SERIES: Genomics
Recorded at: NGx: Applying Next-Generation Sequencing
About this Product:
In this digital course, we present a comprehensive start-to-finish of a multi-assay NGS study. The data comes from 8 breast cancer cell lines; each assayed using the Illumina GA including DNA, small RNA, RNA, and bisulfite methylation sequencing. With the individual assays, we will analyze copy number changes, examine microRNA’s regulatory effects, detect differentially expressed genes, and uncover methylated CpG islands and CpG sites. Finally, we will discuss how to integrate the results to establish biological relationships across multiple genomic mechanisms. Learn how these exciting new technologies can be used along with advanced statistics and dynamic visualizations to get the most biological relevant results from Next Generation Sequencing data.
About this Product:
2 Presentations
Over 109 slides
149 minutes
Single Copy - $345.00
Site License - $1,380.00
Agenda At A Glance:
Start-to-Finish Analysis of a Multi-Assay Next Generation Sequencing Study
Jean Jasinski, Ph.D., Field Application Scientist, Partek
Biography: Jean Jasinski is currently a Field Application Scientist at Partek, Incorporated. After a twenty-year career as a software engineer at Hewlett Packard, Jean switched fields and earned her Ph.D. in Human Medical Genetics from the University of Colorado Health Sciences Center in 2008, where she researched T-cell receptors in autoimmune diabetes. She completed a short postdoctoral position at the Barbara Davis Center for Childhood Diabetes writing software to analyze T cell receptor sequences obtained from Roche 454.
Ryan Peters, M.Sc., Field Application Specialist, Partek
Biography: Ryan Peters is currently a Field Application Specialist at Partek, Incorporated. Ryan earned a B.S. in Biomedical Engineering Washington University in St. Louis, and his M.S. in Genetic Epidemiology from Washington University in St. Louis. His primary focus is the analysis of microarray and next-generation sequencing data and supporting Partek customers across the United States and Canada.
About the Conference:
NGS platforms now generate terabytes of genomic data, calling into question: What is the best way to benefit from this data bonanza? CHI’s Next-Generation Sequencing Data Management combines unique perspectives from a variety of researchers, engineers, biostatisticians, and software developers involved with NGS data management. This team of scientists will present case studies creating a common ground on which to explore how best to store, transfer, and analyze NGS data sets with the common goal of turning data into knowledge.